Você procurou por: intramammary (Inglês - Maltês)

intramammary use
għal użu intramammarju.

intramammary solution
taħlita likwida intramammarja

intramammary infusion, lactating cow
infusjoni intramammarja tal-baqra li qed taħleb

administration: by intramammary infusion only.
amministrazzjoni: permezz ta’ infużjoni intramammarja biss.

antibacterial for intramammary use atcvet code:
kodiċi atc veterinarja:

pharmacotherapeutic group: antibacterial for intramammary use.
grupp farmako-terapewtiku: sustanza għal kontra l-mikrobi għal użu intramammarju.

pirsue 5 mg/ml intramammary solution for cattle
pirsue 5 mg/ml soluzzjoni intramammarja għal baqar

14 package leaflet pirsue 5 mg/ ml intramammary solution for cattle
14 fuljett ta ’ tagĦrif fil- pakkett pirsue 5 mg/ ml soluzzjoni intramammarja għal- baqar.

reduce the risk of new intramammary infections during the dry period, reduce discomfort.
tnaqqis fir-riskju ta’ infezzjonijiet intramammarji ġodda waqt il-perjodu ta’ tnixxif, tnaqqis fl-iskonfort.

8 x 10 ml intramammary syringes 24 x 10 ml intramammary syringes 120 x 10 ml intramammary syringes
120 siringa intramammarja x 10 ml.

the medicinal particular may enter foodstuffs obtained from the treated animal (intramammary preparations).
is-sustanza mediċinali partikolari tista' tidħol f'oġġetti ta' l-ikel miksuba mill-annimal ittrattat (preparazzjonijiet intra-mammarji).

consequently, cabergoline administration induces a reduction of milk production leading to a reduction in udder engorgement and intramammary pressure.
konsegwentement, l-għoti ta’ cabergoline jinduċi tnaqqis fil-produzzjoni ta’ ħalib li jwassal għal tnaqqis fil-mili bil-bżieżel u pressjoni intramammarja.

sterile aqueous solution in 10 ml polyethylene intramammary syringes, packaged as 8 x 10 ml, 24 x 10 ml in an outer cardboard box.
soluzzjoni sterili akweja f’siringi intramammarji tal-polyethylene ta’ 10 ml, ippakkjati f’8 x 10 ml, 24 x 10 ml f’kaxxa tal-kartun.

the efficacy of velactis in reducing the risk of new intramammary infections during the dry period when administered concomitantly with antimicrobial treatment to cows with intramammary infections has not been investigated compared to antimicrobial treatment alone.
l-effikaċja ta’ velactis fit-tnaqqis ta’ infezzjonijiet intramammarji ġodda waqt il-perjodu xott meta jingħata ma’ trattament antimikrobijali fl-istess waqt fil-baqar b’infezzjonijiet intramammarji ma ġietx mistħarrġa meta mqabbla ma trattament waħdu.

after intramammary infusion, mean parent concentrations in milk were 10.3 µg/ ml at 12 hours and 0.77 µg/ ml at 24 hours.
wara infużjoni intramammarja, il- konċentrazzjonijiet medja tas- sustanza oriġinali fil- ħalib kienu ta ’ 10. 3 µg/ ml wara tnax il- siegħa u ta ’ 0. 77 µg/ ml wara erbgħa u għoxrin siegħa.

in a multicentric randomized clinical trial where dairy cows with no intramammary infections at the time of drying-off were administered either velactis or placebo at the time of drying-off, the incidence of new intramammary infections within 7 days after subsequent calving was significantly lower among udder quarters of cows treated with velactis (20.5%) as compared to placebo (26.0%).
fi prova klinika, multiċentrika u każwali fejn baqar tal-ħalib mingħajr infezzjonijiet intramammarji fiż-żmien li ma kinux jaħilbu ngħataw jew velactis jew plaċebo, l-inċidenza ta’ infezzjonijiet intramammarji ġodda fi żmien 7 ijiem wara t-twelid sussegwenti kien b’mod sinjifikanti aktar baxx fost kwart ta’ bżieżel ta’ baqar trattati b’velactis (20.5%) meta mqabbla ma’ plaċebo (26.0%).